|
|
|||||||||||||
|
|
||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Letters to JMG |
1 Ophthalmic Genetics and Visual Function Branch, National Eye Institute, NIH, Bethesda, Maryland, USA, United States
2 L. V. Prasad Eye Institute, Hyderabad, India, India
3 L.V. Prasad Eye Institute, Hyderabad, India, India
4 L. V. Prasad Eye Institute, Hyderabad, India
5 L.V. Prasad Eye Institute, Hyderabad, India
6 Ophthalmic Genetics and Visual Function Branch, National Eye Institute, NIH, Bethesda, Maryland, US, India
* To whom correspondence should be addressed. E-mail: chitra{at}lvpei.org.
Accepted 1 July 2006
| Abstract |
|---|
Purpose: To map and identify the gene for autosomal recessive congenital hereditary endothelial dystrophy (CHED2, OMIM 217700), a disorder characterized by diffuse bilateral corneal clouding that may lead to visual impairment and requiring corneal transplantation.
Methods: Members of 16 families with AR-CHED were genotyped for 13 microsatellite markers at the CHED2 locus on chromosome 20p13-12. Two-point linkage analysis was carried out using the FASTLINK version of the MLINK program. Mutation screening was carried out by PCR amplification of exons and flanking regions followed by direct automated sequencing.
Results: Linkage and haplotype analysis placed the disease locus within a 2.2 cM (1.3 Mb) interval flanked by D20S198 and D20S889 including SLC4A11. The maximum lod score of 11.1 was obtained with D20S117 at q = 0. Sequencing of SLC4A11 showed homozygous mutations in affected individuals from 12 of 16 families.
Conclusion: These results confirm that mutations in the SLC4A11 gene cause AR-CHED.
Keywords: CHED2, SLC4A11, corneal dystrophy, genetics, mapping
This article has been cited by other articles:
![]() |
B. Hemadevi, R. A. Veitia, M. Srinivasan, J. Arunkumar, N. V. Prajna, C. Lesaffre, and P. Sundaresan Identification of Mutations in the SLC4A11 Gene in Patients With Recessive Congenital Hereditary Endothelial Dystrophy Arch Ophthalmol, May 1, 2008; 126(5): 700 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Vithana, P. E. Morgan, V. Ramprasad, D. T.H. Tan, V. H.K Yong, D. Venkataraman, A. Venkatraman, G. H.F. Yam, S. Nagasamy, R. W.K. Law, et al. SLC4A11 mutations in Fuchs endothelial corneal dystrophy Hum. Mol. Genet., March 1, 2008; 17(5): 656 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Desir, G. Moya, O. Reish, N. Van Regemorter, H. Deconinck, K. L David, F. M Meire, and M. J Abramowicz Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy J. Med. Genet., May 1, 2007; 44(5): 322 - 326. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | REGISTER |